Case Study: Blackrock Neurotech improves MoveAgain BCI performance with AE Studio

Blackrock Neurotech boosts BCI decoder performance with AE Studio, supporting 20+ behavioral detectors

AE Studio partnered with Blackrock Neurotech, creator of the only FDA-approved implantable brain-computer interface (BCI) device, to advance their MoveAgain platform. The challenge was to optimize the platform's neural decoders, which faced issues with signal drift between sessions, requiring lengthy recalibration and hindering real-world clinical use for patients with paralysis.

AE Studio implemented a solution using self-supervised learning to improve decoder accuracy and cross-session robustness. They built real-time in-session analysis tools to detect issues and an automated multi-session analytics platform. This resulted in superior decoder performance, reduced retraining time, and the prevention of costly data loss. AE Studio's work directly translated these research improvements into the production MoveAgain platform.

Blackrock Neurotech